IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy

NCT06275893 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Arrhythmogenic Right Ventricular Dysplasia
Arrhythmogenic Left Ventricular Cardiomyopathy
Arrhythmogenic Right Ventricular Cardiomyopathy 1
Arrhythmogenic Cardiomyopathy
ACM
ARVC
PKP2

Interventions

BIOLOGICAL: IC14

Sponsor

Implicit Bioscience